Literature DB >> 5103548

An implanted reservoir of morphine solution for rapid induction of physical dependence in rats.

P G Goode.   

Abstract

1. Rats were dosed continuously with morphine hydrochloride by giving a daily dose through tubes connected to small, subcutaneously implanted reservoirs. Morphine was withdrawn by washing out the reservoir with drug vehicle. The daily dose of morphine, or substitute drug received by each rat was determined by difference by estimating the drug remaining in reservoir washings.2. Withdrawal symptoms were more pronounced after 9 days than after 4 days of dosing with morphine.3. Body weight loss, maximal at 24 h, and increased defaecation during the first 7 h were the chief physiological signs of morphine withdrawal. The body weight loss was the result of hypodipsia and anorexia exacerbated by increased defaecation.4. When substituted for morphine in the reservoir, methadone and codeine completely prevented body weight loss and increased defaecation, while pethidine was effective against increased defaecation, but not against 24 h body weight loss. The opiate-antagonist analgesics pentazocine, nalorphine and cyclazocine either had no effect on withdrawal symptoms or increased their severity.5. In morphine dependent rats under continued morphine administration subcutaneous doses of the opiate-antagonists nalorphine, cyclazocine and naloxone all precipitated the withdrawal symptoms of body weight loss and increased defaecation. The weak antagonist pentazocine caused a significantly increased defaecation, but no significant change in body weight, while the opiates pethidine, codeine and methadone had no significant effect on body weight or defaecation.6. The advantages of inducing dependence by this method of dosing are discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5103548      PMCID: PMC1702867          DOI: 10.1111/j.1476-5381.1971.tb08054.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

Review 1.  PHARMACOLOGICAL ASPECTS OF DRUG DEPENDENCE.

Authors:  G A DENEAU; M H SEEVERS
Journal:  Adv Pharmacol       Date:  1964

2.  Tests for addiction (chronic intoxication) of morphine type.

Authors:  H HALBACH; N B EDDY
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

3.  Administration of pellets of morphine to mice; abstinence syndrome.

Authors:  C MAGGIOLO; F HUIDOBRO
Journal:  Acta Physiol Lat Am       Date:  1961

4.  A new test for morphine-like physical dependence (addiction liability) in rats.

Authors:  W R Buckett
Journal:  Psychopharmacologia       Date:  1964-12-07

5.  The addiction cycle to narcotics in the rat and its relation to catecholamines.

Authors:  T Akera; T M Brody
Journal:  Biochem Pharmacol       Date:  1968-05       Impact factor: 5.858

6.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

  6 in total
  14 in total

1.  Comparison of opiate agonists and their N-allyl derivatives in the production of physical dependence in the rat.

Authors:  M R Fennessy; F J Laska
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

Review 2.  Rational development of addiction pharmacotherapies: successes, failures, and prospects.

Authors:  R Christopher Pierce; Charles P O'Brien; Paul J Kenny; Louk J M J Vanderschuren
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

3.  Effects of the imidazoline I2 receptor agonist 2-BFI on the development of tolerance to and behavioural/physical dependence on morphine in rats.

Authors:  David A Thorn; Yanan Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2016-02-25       Impact factor: 8.739

4.  Conditioned morphine withdrawal in the hamster.

Authors:  P Schnur
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Antinociception and physical dependence produced by [D-Arg2] dermorphin tetrapeptide analogues and morphine in rats.

Authors:  K Chaki; S Kawamura; K Kisara; S Sakurada; T Sakurada; Y Sasaki; T Sato; K Susuki
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

6.  Long-term changes in reward-seeking following morphine withdrawal are associated with altered N-methyl-D-aspartate receptor 1 splice variants in the amygdala.

Authors:  E M Anderson; J K Neubert; R M Caudle
Journal:  Neuroscience       Date:  2012-08-02       Impact factor: 3.590

7.  Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats.

Authors:  J U Adams; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Acute and chronic tolerance to nicotine measured by activity in rats.

Authors:  I P Stolerman; R Fink; M E Jarvik
Journal:  Psychopharmacologia       Date:  1973-06-29

9.  Some properties of WY 22811, a new analgesic compound.

Authors:  P G Goode; A C Shite; D Green
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

10.  Morphine analgesia, tolerance and physical dependence in the adrenalectomized rat.

Authors:  E Wei
Journal:  Br J Pharmacol       Date:  1973-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.